Clin2
NCT05861648Possibly a fitNot yet recruiting

Folic acid for slow aortic valve narrowing

Calcification of Aortic ValveAortic Valve Stenosis

Treatments studied

Part of Heart & circulation clinical trials.

This trial tests whether taking folic acid (a type of vitamin B) can slow the buildup of calcium in the heart's aortic valve. It is for people with early-stage calcific aortic valve disease, and it may help prevent the condition from getting worse.

Summary written for real people, not researchers, by Clin2.

Phase
Phase 2
Enrollment
100 people
Ages
35 years and older
Study type
Interventional

Who can take part

  • You must be at least 35 years old.
  • You have a condition called calcific aortic valve disease, which is when the aortic valve (the heart valve that helps blood flow to your body) becomes stiff with calcium deposits.
  • Your valve narrowing must be mild to moderate — not too severe. This is checked by an ultrasound of your heart (echocardiogram) and a CT scan.
  • You must not have had prior surgery on your aortic valve, or have certain other health conditions like a weak heart pumping (ejection fraction less than 50%), or moderate-to-severe problems with other heart valves.
  • You must be willing to take a daily folic acid supplement or a placebo (a pill with no active ingredient) for the duration of the study, and follow the study plan.

View the official record on ClinicalTrials.gov

Quick eligibility check

Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.

Similar studies

Other trials that look related to this one.

NCT07715279Recruiting· Phase 2
Vericiguat for slowing aortic valve calcium buildup

This trial tests if the drug vericiguat can slow down the buildup of calcium in the aortic valve, which causes it to narrow and stiffen. If you have mild-to-moderate aortic valve stenosis and meet the other criteria, this study may help protect your valve from getting worse.

Chengdu, Sichuan
NCT05875675Not yet recruiting· Phase 2
Pioglitazone for aortic valve disease

This study tests whether pioglitazone, a medicine commonly used for diabetes, can slow the worsening of a condition called calcific aortic valve disease, where calcium builds up on the heart's aortic valve. It may help patients with mild to moderate valve narrowing avoid the need for surgery.

NCT05991271Not yet recruiting
A new valve for a narrowed heart valve

This trial is testing a new, less invasive way to replace a narrowed aortic valve using a special device. The goal is to help improve blood flow and reduce symptoms like chest pain and shortness of breath.

NCT03972644Recruiting
Early valve replacement for people with severe but silent aortic narrowing

This trial tests whether replacing a badly narrowed aortic valve earlier—even when you feel fine—can prevent future heart problems. It compares early valve replacement (through a catheter or surgery) versus standard watchful waiting.

Odense, Fyn
NCT04227002Recruiting
Study for people with aortic valve problems

This trial is for people with aortic valve disease (aortic valve narrowing, leakage, or a worn-out valve). It tests what the doctors learn from following these patients, and it may help improve future care.

Hamburg
NCT07091136Not yet recruiting· Phase 2
Manidipine study for aortic valve calcium buildup

This trial tests an experimental medication to see if it can reduce calcium buildup in the aortic valve, potentially slowing the progression of aortic stenosis. Participants receive the study drug and are monitored with imaging over time.

Hear when a new Aortic Valve Stenosis trial opens

We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.